An observational study in CMV, sponsored by Meridian Bioscience, Inc.. Completed at 5 sites in 4 countries. Open to participants aged Up to 20 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-14.
Sponsored by Meridian Bioscience, Inc. (part of SD Biosensor) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To evaluate the illumigene CMV assay, using the illumipro-10 with neonates (up to 21 days of age) saliva swabs
Meridian Bioscience, Inc. is the lead sponsor of 27 studies on the registry; none are open to participants now.
First submitted before Meridian Bioscience, Inc. became part of SD Biosensor.
Counted across the registry records on this site, refreshed daily.
Saliva swab specimens from all neonates up to 21 days of age may be collected and tested
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: illumigene CMV assay, illumipro-10
CMV assay for detection of CMV
Qualitative detection of CMV to aid in the diagnosis of CMV
Test each sample for CMV detection
Time frame: within 30 days of sample collection
Ran from Aug 2017 to primary completion in Mar 2018, 7 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.